Evolving Treatment Landscape for Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma

被引：1
|
作者：
Wheless, Margaret C. [1 ]
Comer, Margaret [2 ]
Gibson, Michael K. [1 ,3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Sch, Nashville, TN USA
[3] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Med Ctr, 2220 Pierce Ave,777 Preston Res Bldg, Nashville, TN 37232 USA
来源：
CURRENT ONCOLOGY REPORTS | 2024年 / 26卷 / 11期
关键词：
Esophageal Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Claudin18.2; FGFR; HER-2; PD-L1; Therapy; ADVANCED GASTRIC-CANCER; PEMBROLIZUMAB PLUS CHEMOTHERAPY; SQUAMOUS-CELL CARCINOMA; RANDOMIZED PHASE-III; TRASTUZUMAB EMTANSINE; OPEN-LABEL; PRELIMINARY EFFICACY; SOLID TUMORS; DOUBLE-BLIND; CISPLATIN;
D O I：
10.1007/s11912-024-01607-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose of ReviewThis review highlights advances and recent changes in the treatment paradigm for advanced esophageal adenocarcinoma (EAC) and gastroesophageal junction adenocarcinoma (GEJAC).Recent FindingsChemotherapy remains the backbone of treatment for advanced EAC/GEJAC. New targets/agents include immunotherapy, HER-2, claudin18.2, and FGFR2b, with various mechanisms (CAR-T, bispecific mAB, ADCs) altering the treatment landscape against these targets.SummaryThe approaches to these targets may act together, in sequence, and even synergistically to improve outcomes. Herein, we review the state of the field, including highlighting ongoing clinical trials and additional emerging agents and approaches.
引用
收藏
页码：1469 / 1488
页数：20
相关论文
共 50 条
  • [31] EVOLUTION OF TREATMENT STRATEGIES FOR ADENOCARCINOMA OF THE ESOPHAGUS AND GASTROESOPHAGEAL JUNCTION
    WRIGHT, CD
    MATHISEN, DJ
    WAIN, JC
    GRILLO, HC
    HILGENBERG, AD
    MONCURE, AC
    CAREY, RW
    CHOI, NC
    DALY, M
    LOGAN, DL
    ANNALS OF THORACIC SURGERY, 1994, 58 (06): : 1574 - 1579
  • [32] Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States †
    Kim, Bradford J.
    Chiang, Yi-Ju
    Das, Prajnan
    Minsky, Bruce D.
    Blum, Mariela A.
    Ajani, Jaffer A.
    Estrella, Jeannelyn S.
    Hofstetter, Wayne L.
    Tzeng, Ching-Wei D.
    Badgwell, Brian D.
    Mansfield, Paul F.
    Ikoma, Naruhiko
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 16
  • [33] Emerging strategies in the treatment of advanced esophageal, gastroesophageal junction, and gastric cancer: the introduction of targeted therapies
    T. Macarulla
    C. Valverde
    F. J. Ramos
    E. Casado
    E. Martinelli
    J. Tabernero
    A. Cervantes
    Targeted Oncology, 2006, 1 : 23 - 33
  • [34] Pembrolizumab for first-line treatment of advanced unresectable or metastatic esophageal or gastroesophageal junction cancer
    Hirose, Toshiharu
    Yamamoto, Shun
    Kato, Ken
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [35] Emerging strategies in the treatment of advanced esophageal, gastroesophageal junction, and gastric cancer: the introduction of targeted therapies
    Macarulla, T.
    Valverde, C.
    Ramos, F. J.
    Casado, E.
    Martinelli, E.
    Cervantes, A.
    Tabernero, J.
    TARGETED ONCOLOGY, 2006, 1 (01) : 23 - 33
  • [36] Safety and efficacy of tislelizumab plus chemotherapy for first-line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma
    Qiu, Hai-Bo
    THORACIC CANCER, 2020, 11 (12) : 3419 - 3421
  • [37] Treatment and testing patterns among patients with HER21 advanced/metastatic gastric, esophageal or gastroesophageal junction (GEJ) adenocarcinoma in the United States
    Janjigian, Y.
    Hess, L.
    Zhu, Y.
    Fang, Y.
    Liepa, A.
    Kuder, C.
    Chin, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [38] (Neo)Adjuvant Treatment of Locally Advanced Esophageal and Gastroesophageal Adenocarcinoma: Special Focus on Sex Differences
    Zander, Thomas
    Wagner, Anna Dorothea
    CANCERS, 2022, 14 (04)
  • [39] Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
    Catenacci, Daniel V.
    Chao, Joseph
    Muro, Kei
    Al-Batran, Salah Eddin
    Klempner, Samuel J.
    Wainberg, Zev A.
    Shah, Manish A.
    Rha, Sun Young
    Ohtsu, Atsushi
    Liepa, Astra M.
    Knoderer, Holly
    Chatterjee, Anindya
    Van Cutsem, Eric
    ONCOLOGIST, 2021, 26 (10): : E1704 - E1729
  • [40] Concurrent versus sequential neoadjuvant chemoradiation therapy for esophageal and gastroesophageal junction adenocarcinoma
    Torphy, Robert J.
    Ho, Felix
    Friedman, Chloe
    Leong, Stephen
    Wani, Sachin
    Scott, Christopher D.
    Weyant, Michael J.
    Meguid, Robert A.
    Gleisner, Ana
    Goodman, Karyn A.
    McCarter, Martin D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345